Orlando M. Gutiérrez, M.D., M.MSc., Chair, Medical Affairs
Dr. Orlando Gutiérrez serves on the American Kidney Fund Board of Trustees as Chair of the Medical Affairs and Clinical Scientist in Nephrology Committees. He also serves on the Health Insurance Premium Program (HIPP) and Executive Committees, and as Chair of the Medical Advisory Committee.
Dr. Gutiérrez received his medical degree from the University of Toledo College of Medicine in 2002. He completed internship and residency training at Massachusetts General Hospital in Boston from 2002 to 2005, and a clinical and research fellowship in nephrology from the Brigham and Women’s Hospital/Massachusetts General Hospital Joint Nephrology Training Program in 2008. With the support of an American Kidney Fund Clinical Scientist in Nephrology fellowship award, he completed a Master of Medical Science degree in human clinical investigation from Harvard Medical School during his fellowship, graduating as valedictorian of his class.
Dr. Gutiérrez joined the faculty of the Division of Nephrology and Hypertension at the University of Miami Miller School of Medicine as an assistant professor of medicine in 2008. He was then recruited to the University of Alabama (UAB) at Birmingham in 2011, where he is an associate professor of medicine in the School of Medicine and Epidemiology in the School of Public Health. In addition, he serves as the section head for outcomes and epidemiology research in the Division of Nephrology at UAB.
Dr. Gutiérrez’s research is focused on understanding pathophysiological mechanisms underlying disorders of phosphorus and vitamin D metabolism in health and in individuals with kidney disease. He has a special interest in delineating environmental and/or behavioral factors that may modulate these associations, particularly those related to poverty and nutrition. His research has been published in high-impact journals such as the New England Journal of Medicine and Circulation, and he has been an invited speaker in numerous national and international conferences. He is currently supported by a grant from the NIH and American Heart Association.